Vacunas antivirales existentes
dc.contributor.author | Mendoza, Natalia | |
dc.contributor.author | Creed, Rosella | |
dc.contributor.author | Satyaprakash, Anita K. | |
dc.contributor.author | Ravanfar, Parisa | |
dc.date.accessioned | 2021-02-22T15:53:50Z | |
dc.date.available | 2021-02-22T15:53:50Z | |
dc.date.issued | 2009 | |
dc.description.abstract | La innovación de las vacunas ha permitido uno de los mayores avances en la historia de la salud pública. La primera de las vacunas han sido las vacunas antivirales, en particular la vacuna contra la viruela que fue desarrollada por primera vez por Edward Jenner en 1796. Este artículo revisará la vacunación para las siguientes enfermedades virales: sarampión, paperas, rubéola, polio, hepatitis A, hepatitis B , influenza, rotavirus, rabia, viruela del simio, viruela, encefalitis japonesa y fiebre amarilla. | spa |
dc.description.abstractenglish | The innovation of vaccines has allowed for one of the greatest advancements in the history of public health. The first of the vaccines have been the antiviral vaccines, in particular the smallpox vaccine that was first developed by Edward Jenner in 1796. This article will review vaccination for the following viral diseases: measles, mumps, rubella, polio, hepatitis A, hepatitis B, influenza, rotavirus, rabies, monkeypox, smallpox, Japanese encephalitis, and yellow fever. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1111/j.1529-8019.2009.01224.x | |
dc.identifier.instname | instname:Universidad El Bosque | spa |
dc.identifier.issn | 1529-8019 | |
dc.identifier.reponame | reponame:Repositorio Institucional Universidad El Bosque | spa |
dc.identifier.repourl | repourl:https://repositorio.unbosque.edu.co | |
dc.identifier.uri | https://hdl.handle.net/20.500.12495/5408 | |
dc.language.iso | eng | |
dc.publisher | Wiley Online Library | spa |
dc.publisher.journal | Dermatologic Therapy | spa |
dc.relation.ispartofseries | Dermatologic Therapy; 1529-8019, Vol. 22, Nro. 2, 2009, p.110-128 | spa |
dc.relation.uri | https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1529-8019.2009.01224.x | |
dc.rights.accessrights | https://purl.org/coar/access_right/c_abf2 | |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
dc.rights.accessrights | Acceso abierto | |
dc.rights.creativecommons | 2009-03 | |
dc.rights.local | Acceso abierto | spa |
dc.subject | Antivírico | spa |
dc.subject | Hepatitis | spa |
dc.subject | Influenza | spa |
dc.subject | Vacuna | spa |
dc.subject.keywords | Antiviral | spa |
dc.subject.keywords | Hepatitis | spa |
dc.subject.keywords | Influenza | spa |
dc.subject.keywords | MMR | spa |
dc.subject.keywords | Vaccine | spa |
dc.title | Vacunas antivirales existentes | spa |
dc.title.translated | Existing antiviral vaccines | spa |
dc.type.coar | https://purl.org/coar/resource_type/c_6501 | |
dc.type.driver | info:eu-repo/semantics/article | |
dc.type.hasversion | info:eu-repo/semantics/publishedVersion | |
dc.type.local | Artículo de revista |